Measures | Control group | Tα1 group | Between groups difference |
---|---|---|---|
 | Mean (95% CI) | Mean (95% CI) |  |
SOFA score | Â | Â | Â |
   Day 0 | 7.7 (6.8-8.5) | 7.9 (7.0-8.7) |  |
   Day 3 | 6.4 (5.6-7.2) | 6.1 (5.2-6.9) |  |
   Day 7 | 5.9 (5.0-6.7) | 5.3 (4.5-6.2) |  |
   ΔDay 3* | -1.3 (-1.7--0.8)a | -1.8 (-2.3--1.4)a | -0.5 (-1.2-0.1) |
   ΔDay 7* | -1.8 (-2.4--1.3)a | -2.5 (-3.1--2.0)a | -0.7 (-1.5-0) |
mHLA-DR (%) | Â | Â | Â |
   Day 0 | 58.2 (38.8-77.6) | 51.8 (32.5-71.2) |  |
   Day 3 | 62.2 (42.8-81.6) | 59.8 (40.4-79.2) |  |
   Day 7 | 69.4 (50.0-88.8) | 68.9 (49.5-88.2) |  |
   ΔDay 3* | 4.1 (1.4-6.7)b | 8.0 (5.4-10.5)b | 3.9 (0.2-7.6)a |
   ΔDay 7* | 11.2 (7.8-14.7)b | 17.0 (13.7-20.3)b | 5.8 (1.0-10.5)a |
CD4+/CD8+ | Â | Â | Â |
   Day 0 | 2.4 (2.0-2.9) | 2.5 (2.0-2.9) |  |
   Day 3 | 2.7 (2.2-3.1) | 2.7 (2.3-3.2) |  |
   Day 7 | 2.4 (2.0-2.9) | 2.5 (2.1-3.0) |  |
   ΔDay 3* | 0.2 (0-0.5) | 0.3 (0-0.5)a | 0 (-0.3-0.4) |
   ΔDay 7* | 0 (-0.3-0.3) | 0.1 (-0.2-0.4) | 0.1 (-0.3-0.5) |